ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
March 25, 2021Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics such as vaccines and therapeutics for the world's most debilitating diseases, and Dynavax Technologies Corporation, a biopharmaceutical ... -
First Participant Dosed in COVID-19 Vaccine Trial in Taiwan, China Region
January 29, 2021Medigen Vaccine Biologics (MVC) and Dynavax Technologies announced the first participant has been dosed in the Phase 2 clinical trial evaluating MVC's COVID-19 vaccine candidate, MVC-COV1901. -
Indian firm Biological E initiates clinical trial of Covid-19 vaccine candidate
November 17, 2020Indian pharma firm Biological E (BE) has initiated a Phase I/II clinical trial to evaluate the safety and immunogenicity of its Covid-19 subunit vaccine candidate. -
Valneva, Dynavax Enter COVID-19 Vax Supply Pact
September 16, 2020Dynavax will supply CpG 1018 to produce up to 100 million doses of VLA2001 vaccine in 2021.
Pharma Sources Insight January 2025
